In 2014, by means of exome sequencing it was determined that a genetic mutation of the SLC13A5 gene is the cause of an extremely rare citrate transporter disorder.
Mutations in SLC13A5 cause autosomal recessive epileptic encephalopathy with seizure onset in the first days of life. Those afflicted suffer from seizures, global developmental delay, movement disorder and hypotonia.
Inoue, K.; Zhuang, L.; Ganapathy, V. (2002). "Human Na+ -coupled citrate transporter: Primary structure, genomic organization, and transport function". Biochemical and biophysical research communications299 (3): 465–471. doi:10.1016/S0006-291X(02)02669-4. PMID12445824.edit
Gopal, E.; Miyauchi, S.; Martin, P. M.; Ananth, S.; Srinivas, S. R.; Smith, S. B.; Prasad, P. D.; Ganapathy, V. (2006). "Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines". AJP: Gastrointestinal and Liver Physiology292 (1): G402–G408. doi:10.1152/ajpgi.00371.2006. PMID16973915.edit